Noble Financial Initiates Coverage of Cosmos Health with Buy Rating
Noble Financial analyst Michael Kupinski has initiated coverage on Cosmos Health (COSM) with a buy rating and a price target of $1.40.
Stocks · News reference
Cosmos Health shares are trading higher after the company announced that its United States direct-to-consumer sales reached a record of more than $92,000 in a single day on October 11, 2026.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Cosmos Health Expands E-Commerce and Subscription Business to Oceania
Cosmos Health Inc. has launched its e-commerce and subscription business in Australia, New Zealand, and the broader Oceania region, with sales already underway.
8-K filing — Cosmos Health Inc. (COSM)
Filed: 2026-10-22 AccNo: 0001477932-26-006396 Size: 625 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Cosmos Health Expects Q4 Sales Of ~$15M, Gross Profit Of ~$10.5M With Gross Margin Of ~70%
● Subscription revenue: approximately $11.5 million expected, from approximately $8.2 million in first orders and approximately $3.3 million in renewals● Order volume: 14,624 online checkout orders tracked as of October